Residents Can Ditch CPAP Masks With New UAE Sleep Apnoea Implant

Lifestyle,  Technology
Person sleeping comfortably mask-free; small hypoglossal nerve stimulator patch and chip on bedside table
Published February 19, 2026

The United Arab Emirates’s Sheikh Shakhbout Medical City has launched a coin-sized hypoglossal nerve stimulator implant, giving adults with moderate to severe obstructive sleep apnoea a mask-free, second-line treatment when CPAP therapy fails.

Why This Matters

Minimally invasive placement under the chin cuts down on scarring and recovery time.

Nightly external activation uses a rechargeable chip and adhesive patch—no bulky masks.

Tailored for AHI 15–65 in patients with BMI up to 35 kg/m² who can’t tolerate CPAP.

Insurance pathways opening: Cigna covers the implant; other UAE insurers are evaluating policies.

Shedding New Light on Sleep Apnoea in the UAE

Obstructive sleep apnoea affects an estimated 20–25% of Emirati adults, driven in part by high obesity rates. Left unaddressed, it’s linked to hypertension, type 2 diabetes, and a two-fold rise in road-traffic accidents. Continuous positive airway pressure (CPAP) remains the standard, but up to 40% of users abandon it due to discomfort, heat and noise—especially in the summer months.

How the Implant Works

Surgeons at SSMC perform a 45-minute day procedure under local or light general anaesthesia, tucking the leadless stimulator beneath the chin. At bedtime, patients attach a disposable adhesive patch paired with a rechargeable activation chip. Pulses deliver bilateral stimulation to the hypoglossal nerve and synchronise with each breath, keeping the airway open without external machinery.

Navigating Eligibility and Costs

Prospective candidates undergo:

Sleep study confirming an Apnoea–Hypopnoea Index between 15 and 65.

Endoscopic assessment to rule out complete concentric soft-palate collapse.

BMI check—up to 35 kg/m² is acceptable.

Cigna Healthcare has deemed the implant medically necessary as of March 2026. Daman, ADNIC and Sukoon require pre-authorisation and a detailed medical-necessity letter. Out-of-pocket portions vary but are said to align with cochlear implant surgery once reimbursement applies. Patients should confirm with HR or corporate schemes for enhanced surgical caps.

Training, Research and Regional Reach

Under a recent Memorandum of Understanding with Belgian med-tech firm Nyxoah, SSMC will establish a regional Genio training hub, equipping Gulf surgeons and sleep specialists with hands-on expertise. Parallel studies will track long-term outcomes, feeding data into the UAE’s National AI Strategy 2031 for predictive health-tech modeling.

What This Means for Residents

Seek early screening if you snore regularly—many insurers require polysomnography within 12 months.Plan for consumables: the annual cost of adhesive patches approximates a basic telecom plan.Tap into employer plans: corporate insurance often covers a higher share of surgical fees.Benefit from local expertise: with SSMC’s training hub, expect shorter waiting lists and fewer referrals abroad.

This implantable therapy positions the United Arab Emirates at the forefront of sleep-disordered breathing treatment, promising better health outcomes and quality of life for hundreds of thousands of residents unable to tolerate conventional CPAP solutions.